» Articles » PMID: 31883520

Insulin Autoimmune Syndrome Induced by Exogenous Insulin Injection: a Four-case Series

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2019 Dec 30
PMID 31883520
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insulin autoimmune syndrome (IAS) is a rare cause of hypoglycemia and is characterized by the presence of insulin autoantibodies. Patients with IAS usually complain of hypoglycemia without any previous insulin received. Glucocorticoids and immunosuppressants are used to treat IAS.

Case Presentation: We report four patients with diabetes who were diagnosed with non-classical IAS and describe the treatment of these patients. Moreover, the differential diagnosis with hyperinsulinism is discussed.

Conclusion: High levels of insulin autoantibodies, as well as hyperinsulinemic hypoglycemia, are found in patients with diabetes mellitus and prior exogenous insulin exposure. This situation that we classified as non-classical IAS should be attached importance to.

Citing Articles

Insulin Autoimmune Syndrome: A Chinese Expert Consensus Statement.

Zhang H, Yuan M, Pan Q Aging Med (Milton). 2025; 8(1):e70007.

PMID: 39990629 PMC: 11845856. DOI: 10.1002/agm2.70007.


Levels of anti-insulin antibodies in diabetic retinopathy patients: an observational cross-sectional study.

Mohammed B, Ofori E, Adekena C, Amponsah S, Asare-Anane H, Amanquah S Future Sci OA. 2024; 10(1):FSO982.

PMID: 38817369 PMC: 11137838. DOI: 10.2144/fsoa-2024-0002.


A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia.

Kubo H, Sugimoto K, Wada R, Sekikawa N, Inoue M Cureus. 2024; 16(4):e58461.

PMID: 38765413 PMC: 11100447. DOI: 10.7759/cureus.58461.


Exogenous insulin autoimmune syndrome: A case report and review of literature.

Xu L, Chen J, Cheng J, Luo N World J Clin Cases. 2024; 12(9):1691-1697.

PMID: 38576740 PMC: 10989436. DOI: 10.12998/wjcc.v12.i9.1691.


The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies.

Hua K, Jing B, Wu Y Diabetes Metab Syndr Obes. 2023; 16:1121-1132.

PMID: 37122678 PMC: 10134342. DOI: 10.2147/DMSO.S404222.


References
1.
Stafeev I, Vorotnikov A, Ratner E, Menshikov M, Parfyonova Y . Latent Inflammation and Insulin Resistance in Adipose Tissue. Int J Endocrinol. 2017; 2017:5076732. PMC: 5585607. DOI: 10.1155/2017/5076732. View

2.
Boucher J, Kleinridders A, Kahn C . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014; 6(1). PMC: 3941218. DOI: 10.1101/cshperspect.a009191. View

3.
Ohtsuka Y, Kondo T, Shimada M, Murakami K, Ide H, Kawakami Y . Erythrocyte insulin receptor in insulin autoimmune syndrome: effects of corticosteroid therapy. Tohoku J Exp Med. 1987; 151(2):181-90. DOI: 10.1620/tjem.151.181. View

4.
Rajpal A, Sayyed Kassem L, Moscoso-Cordero M, Arafah B . Clopidogrel-Induced Insulin Autoimmune Syndrome: A Newly Recognized Cause of Hypoglycemia in a Patient Without Diabetes. J Endocr Soc. 2017; 1(9):1217-1223. PMC: 5686698. DOI: 10.1210/js.2017-00316. View

5.
Saxon D, McDermott M, Michels A . Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016; 101(5):1931-4. DOI: 10.1210/jc.2016-1097. View